Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma

  1. Grünwald, V.
  2. Larkin, J.
  3. Puente, J.
  4. Bedke, J.
  5. Porta, C.
Revue:
Clinical Genitourinary Cancer

ISSN: 1938-0682,  1558-7673

Année de publication: 2024

Volumen: 22

Número: 2

Pages: 394-401

Type: Note

DOI: 10.1016/J.CLGC.2023.12.010 GOOGLE SCHOLAR
La source de données: Scopus